News

Unanet's AI-first Platform Honored with CRM Award

Unanet's AI-first Platform Honored with CRM Award

Unanet's Remarkable Recognition

There it is—Unanet snagging the esteemed CRM Excellence Award for 2026, spotlighted in CUSTOMER Magazine. This nod from a decades-old authority in contact center tech doesn't happen by luck—it's the culmination of strategic brilliance. Unanet's been busy redefining what it means to be AI-first, and now they're reaping the rewards.

Power of AI in Project Management

Unanet's growth hasn't just been about tacking AI onto old processes. No, these guys flipped the script, reimagining how GovCons sync up with potential projects. The AI-driven GrowthStudio platform is at the core of it all. Rather than relying on the same ol' methods, businesses can now zero in on juicy opportunities that play to their strengths, without reshuffling the team deck.

CEO Craig Halliday laid it out clearly, emphasizing that the goal isn't to make processes painfully smarter, but actionable, practical smart. It's one thing to have a vision; it's another to deliver tangible, predictable growth with AI's quicksilver power.

"Our AI-first strategy isn't about adding AI to existing workflows—it's about fundamentally reimagining how GovCons identify opportunities, make smarter decisions, and grow their business." — Craig Halliday

Transforming the Traditional

The CRM Excellence Award isn't handed out just based on glitzy tech features. It's about concrete results, which Unanet has in spades. In their 10th annual GAUGE Report, the company dropped a bombshell: GovCons leveraging AI in operations win over half of their targeted opportunities. That's an edge you can't ignore—the kind of advantage that turns heads and wins awards.

Delving Into the CRM Excellence Criteria

Let me tell you, customer loyalty ain't what it used to be—it's far more dynamic and requires tech that can keep pace. The CRM Excellence Awards recognize companies that don't just manage customer relationships; they enhance every touchpoint across the board. Unanet's GrowthStudio, as part of its AI-first package, meets and exceeds these expectations. By automating mundane tasks, diving headlong into analytics, and building robust customer solutions, Unanet's practices shape into loyalty machines.

  • Streamlined Processes: Cutting redundancy and upping efficiency.
  • Enhanced Engagement: Leveraging insights to keep clients hooked.
  • Long-term Loyalty: Transforming user interactions into lasting bonds.

The Legacy and Future of Awards

A quick tip of the hat to Rich Tehrani, CEO of TMC, shedding light on the significance of these recognitions. The CRM Excellence Award isn't just another plaque for Unanet; it's validation. Unanet's accolades shine brighter than most in the marketplace, carrying almost three decades of historic respect. This isn’t just about pats-on-the-back; it's proof in the pudding—real-world performance that’s altering client organizations for the better.

Looking ahead, with this award in their pocket and AI-first strategy under their belt, Unanet’s walking down a path of increased trust and innovative reputation. Yeah, others might play catch-up, but Unanet's placed itself solidly at the AI-in-ERP forefront, potentially dictating how future market maneuvers play out.

The Path Ahead

Smart investors and market observers are bound to keep Unanet on their radar. With a coalition of over 4,200 GovCons and engineering firms, they're more than just a flash in the pan. They're setting themselves up to be a cornerstone in predictive, AI-driven project management.

With a tech landscape this frenetic, it's outfits like Unanet—sharp, innovative, and recognized—that are likely to continue etching out the blueprint for how project-based businesses capture growth and elevate strategies. Keep an eye peeled, because the moves they make could echo well beyond this CRM accolade.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BioVid Debuts AI to Mimic Physician Decision-Making

Updated Category News Views 47

Revolutionizing Understanding: BioVid Mimetics™ Now here's something that's shaking the research tree: BioVid's launching Mimetics™, and it's a big deal. They've come up with AI that can mirror how physicians think and decide. This ain't your run-of-the-mill tech stuff—it's groundbreaking in understanding physician decision-making. The Core: How Do Doctors Really...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 111

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
AZ Health Workers Step Up for Community Wellness

Updated Category News Views 4

Health Screenings: A Step Before the Hospital Sometimes it's the basics, like a plain old health screening, that can shift the tides from crisis to care. That's exactly where AZ Blue Health Choice and Zeihan ProHealth come into the picture, aiming to pin those health concerns before they spiral out of control. For your average Arizonan who finds healthcare as elusive as a...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 94

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 57

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Home Insurance Gaps: Risky Assumptions Uncovered

Updated Category News Views 53

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Continue Reading
Americas Cardroom Smashes Prize Pools; Bahamas Up Next

Updated Category News Views 49

Ah, poker. Where dreams are won with a flick of the wrist and a well-placed bluff. This week, it was all eyes on Americas Cardroom’s Dual Venom PKOs, and let me tell you, they didn't just meet expectations—they chewed them up and spat them out like yesterday's jam. Two Titans Crowned in Poker Showdown The action wrapped up with a jaw-dropping $6,862,500 prize pool....

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 14

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 4

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading

Top 5 Most Recently Viewed Articles

Clare Locke Advocates for Megan Thee Stallion in Defamation Case

Updated Category News Views 111

Clare Locke LLP Champions Megan Thee Stallion's Defamation Case Clare Locke LLP, a respected name in defamation law, has taken a bold step to support Megan Thee Stallion's pursuit of justice against Milagro Cooper. The firm has filed a motion for leave to present an amicus brief that specifically endorses Megan's effort to have a jury's defamation ruling reinstated. This...

Continue Reading
Bankers Signal Looming Economic Challenges Amid Uncertainty

Updated Category News Views 167

Bankers Signal Looming Economic Challenges Amid Uncertainty Interest rate fluctuations, credit quality, and tariffs are significant concerns for financial institutions. A recent survey highlights the anxiety among bankers regarding the economic climate and impending recession. Survey Highlights Economic Fears According to a survey from fintech IntraFi, which gathered...

Continue Reading
Dave Portnoy Questions Elon Musk Amid Tesla's Plummeting Stock

Updated Category News Views 162

Tesla's Stock Dilemma: Portnoy's Concerns Tesla’s stock, designated as TSLA, has recently experienced a significant decline, stirring up discussions among investors and enthusiasts alike. Dave Portnoy, the founder of Barstool Sports, has voiced his frustration regarding this situation, bringing forth some pointed questions about Elon Musk’s priorities. In a recent...

Continue Reading
Akropolis Group's Credit Rating Affirmed Amid Strategic Changes

Updated Category News Views 88

Akropolis Group’s Robust Credit Rating Amid Strategic Reassessments Renowned international credit rating agency S&P Global Ratings recently evaluated the financial outlook for Akropolis Group, a prominent player in the real estate development and management sector. This assessment took into account significant structural governance changes within the Vilniaus Prekyba...

Continue Reading
Arcutis Takes a Significant Step with ZORYVE Cream for Kids

Updated Category News Views 156

Arcutis Advances ZORYVE® Cream for Pediatric Use Arcutis Biotherapeutics, Inc. is making headlines with its recent submission of a supplemental New Drug Application (sNDA) aimed at expanding the use of ZORYVE (roflumilast) cream 0.3% to treat plaque psoriasis in children as young as 2 years old. If approved, ZORYVE would be the first topical PDE4 inhibitor specifically...

Continue Reading